Search research articles
Contact Us
Filters
Showing results (111-120 of 320) with videos related to
Page
of 32
Sort By:
European Journal of Preventive Cardiology
|
September 26, 2013
Relationships between consumption of alcoholic beverages and healthy foods: the French supermarket cohort of 196,000 subjects
Boris Hansel, Ronan Roussel, Vincent Diguet, et al.
Atherosclerosis
|
November 7, 2025
Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know
M John Chapman, Chris J Packard, Elias Björnson, et al.
Pharmacology & Therapeutics
|
November 8, 2015
Therapeutic applications of reconstituted HDL: When structure meets function
Maryam Darabi, Isabelle Guillas-Baudouin, Wilfried Le Goff, et al.
Clinical Chemistry and Laboratory Medicine
|
April 6, 2004
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
Jean-Louis Beaudeux, Philippe Giral, Eric Bruckert, et al.
Journal of the American College of Cardiology
|
August 1, 2020
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review
Julius L Katzmann, Chris J Packard, M John Chapman, et al.
Current Medical Research and Opinion
|
July 19, 2006
One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study
Boris Hansel, Anatol Kontush, Philippe Giral, et al.
Biochimica Et Biophysica Acta
|
February 8, 2003
VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass
Dragana Milosavljevic, Anatol Kontush, Sabine Griglio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2002
Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia
Maryse Guerin, Pascal Egger, Wilfried Le Goff, et al.
Psychological Assessment
|
May 2, 2012
Development and validation of the Delinquency Reduction Outcome Profile (DROP) in a sample of incarcerated juveniles: a multiconstruct/multisituational scoring approach
Baptiste Barbot, Gerald J Haeffel, Donna Macomber, et al.
Journal of the American Society of Nephrology : JASN
|
March 7, 2000
Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine
Chantal Doucet, Vincent Mooser, Sophie Gonbert, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 320) with videos related to
Sort By:
Page
of 32
European Journal of Preventive Cardiology
|
September 26, 2013
Relationships between consumption of alcoholic beverages and healthy foods: the French supermarket cohort of 196,000 subjects
Boris Hansel, Ronan Roussel, Vincent Diguet, et al.
Atherosclerosis
|
November 7, 2025
Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know
M John Chapman, Chris J Packard, Elias Björnson, et al.
Pharmacology & Therapeutics
|
November 8, 2015
Therapeutic applications of reconstituted HDL: When structure meets function
Maryam Darabi, Isabelle Guillas-Baudouin, Wilfried Le Goff, et al.
Clinical Chemistry and Laboratory Medicine
|
April 6, 2004
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
Jean-Louis Beaudeux, Philippe Giral, Eric Bruckert, et al.
Journal of the American College of Cardiology
|
August 1, 2020
Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review
Julius L Katzmann, Chris J Packard, M John Chapman, et al.
Current Medical Research and Opinion
|
July 19, 2006
One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitié Study
Boris Hansel, Anatol Kontush, Philippe Giral, et al.
Biochimica Et Biophysica Acta
|
February 8, 2003
VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass
Dragana Milosavljevic, Anatol Kontush, Sabine Griglio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 5, 2002
Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia
Maryse Guerin, Pascal Egger, Wilfried Le Goff, et al.
Psychological Assessment
|
May 2, 2012
Development and validation of the Delinquency Reduction Outcome Profile (DROP) in a sample of incarcerated juveniles: a multiconstruct/multisituational scoring approach
Baptiste Barbot, Gerald J Haeffel, Donna Macomber, et al.
Journal of the American Society of Nephrology : JASN
|
March 7, 2000
Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine
Chantal Doucet, Vincent Mooser, Sophie Gonbert, et al.
Page
of 32